Clinical Trial
Evaluation of trifluperidol in chronic schizophrenia
- PMID: 4916807
Item in Clipboard
Clinical Trial
Evaluation of trifluperidol in chronic schizophrenia
Psychopharmacologia.
1968.
No abstract available
Similar articles
-
Evaluation of trifluperidol in chronic schizaphrenia.Psychopharmacologia. 1968;12(3):193-203. Psychopharmacologia. 1968. PMID: 4917285 Clinical Trial. No abstract available.
-
[Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].Act Nerv Super (Praha). 1970 Jan 12;12(1):56-7. Act Nerv Super (Praha). 1970. PMID: 4907390 Clinical Trial. Czech. No abstract available.
-
Management of the schizophrenic patient in a community psychiatric practice.Dis Nerv Syst. 1968 May;29(5):Suppl:27-34. Dis Nerv Syst. 1968. PMID: 4876987 Clinical Trial. No abstract available.
-
Drug therapy.Prog Neurol Psychiatry. 1969;24:478-97. Prog Neurol Psychiatry. 1969. PMID: 4905451 Review. No abstract available.
-
Drug therapy.Prog Neurol Psychiatry. 1972;27:339-54. Prog Neurol Psychiatry. 1972. PMID: 4575598 Review. No abstract available.
Cited by
-
Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials.BMC Med. 2005 Oct 17;3:15. doi: 10.1186/1741-7015-3-15. BMC Med. 2005. PMID: 16229742 Free PMC article.
-
Chlorpromazine versus placebo for schizophrenia.Cochrane Database Syst Rev. 2014 Jan 6;2014(1):CD000284. doi: 10.1002/14651858.CD000284.pub3. Cochrane Database Syst Rev. 2014. PMID: 24395698 Free PMC article.
-
Placebo response in antipsychotic clinical trials: a meta-analysis.JAMA Psychiatry. 2014 Dec 1;71(12):1409-21. doi: 10.1001/jamapsychiatry.2014.1319. JAMA Psychiatry. 2014. PMID: 25321611 Free PMC article.